AzTrials
AzTrials

Iron Deficiency Without AnemiaNCT03002090

Defining the Functional Role of Iron in Aerobic Training and Physical Performance

A study testing Iron trained, Iron Untrained and BZKL Trained in people with Iron Deficiency Without Anemia, run by Cornell University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Iron deficiency is known to negatively impact physical performance, attention, and time spent doing physical activity. As a result, an iron deficient person must expend more energy to complete the same amount of work as someone who is healthy. Read more about this study

Who is it for?
Ages 18 to 26 years, women only
Conditions the study is for
Iron Deficiency Without Anemia
What is being tested?
Iron trained, Iron Untrained and BZKL Trained
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
109 participants
Where
1 siteChina
Study dates
Aug 2014to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 26 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-26
  • Must be able to complete exercise on a stationary bicycle
  • Clinical diagnosis of iron depletion without severe anemia (sFer< 25µg/L, Hb>110g/L)
  • Willing to comply with the 8-week supplementation and if assigned, training program

Who cannot join

  • age less than 18
  • severe anemia (Hb<90g/L in blood analyses)
  • current pregnancy or pregnancy within the previous year
  • recent infectious illness or fever
  • current inflammation or chronic inflammatory diseases (AGP > 1.0 g/L in blood analyses)
  • hemolytic anemia
Show all 12Show fewer
  • chronic respiratory disease
  • musculoskeletal problems
  • history of eating disorders
  • smoking, BMI < 18 or >24 kg/m2
  • consumption of medications that may affect dietary iron intake or absorption or that have anticoagulant properties
  • participation in varsity sports team

Trial locations and contacts

1 site in 1 country.

China1 site
  • Kunming Medical University, Department of Nursing,

    Longcheng, Yunnan

Other trials in China

About this study

Official title: Defining the Functional and Metabolic Role of Iron in Aerobic Training and Physical Performance

Iron deficiency is known to negatively impact physical performance, attention, and time spent doing physical activity. As a result, an iron deficient person must expend more energy to complete the same amount of work as someone who is healthy. Another interesting relationship has been observed between exercise training and iron status in that women who participate in exercise training often have higher rates of iron deficiency than sedentary women. ID is commonly treated using daily iron supplementation. However, it is currently unknown whether participating in regular exercise somehow impacts the effectiveness of iron supplementation. Iron deficient women who participate in exercise programs may potentially benefit less from iron supplementation than those who do not. Another common treatment for the symptoms of iron deficiency is the traditional Chinese herbal treatment, Ba-Zhen-Ke-Li (BZKL). While studies have shown that BZKL impacts expression of some iron-related proteins and increases endurance performance in rats, no studies have examined the efficacy of BZKL in improving iron markers or physical performance in humans. This study will compare the efficacy of BZKL in improving iron status and physical performance with that of ferrous sulfate supplementation. The Cornell research team will achieve these objectives in collaboration with colleagues at Kunming Medical University (KMU) in Kunming, China. A double-blind, randomized, placebo controlled study will be conducted by a Cornell graduate student at KMU. The subjects will be healthy women, age 18-26 years, attending KMU. Blood samples will be collected and analyzed for measures of iron).

Subjects will be randomly assigned to receive 50 mg of ferrous sulfate (10 mg of elemental iron), 6mg of BZKL, or an identical placebo pill twice daily for 8 weeks. Subjects will be further randomly sub-divided to receive aerobic exercise training or no training during the 8-week supplementation period. At weeks 4 and 8, subjects will perform the same series of tests as was performed at baseline. The investigators hypothesize that: 1. the women who train and received iron will have smaller improvements in iron status than those who do not train 2. The women who receive iron and train will have greater improvements in physical performance than those who train and do not receive iron, and 3. The women who receive BZKL will improve their iron status or physical performance more than those who receive placebo.

Read the detailed description

Background: Despite the overall improvements in malnutrition in the Chinese population, iron deficiency (ID) and iron deficiency anemia (low iron and low hemoglobin, IDA) are still widely prevalent in China. According to recent studies, the prevalence of anemia in Chinese women of childbearing age is 20% and can be as high as 30% in rural areas, with 85% of anemia cases resulting from ID. Diabetes, heart disease, and obesity are also highly prevalent in China - though the Chinese government is taking actions against these epidemics, often via interventions promoting physical activity. Iron deficiency without anemia (IDNA) can impair adult physical performance and lowers time spent doing voluntary physical activities. However, iron supplementation intended to alleviate IDNA may be less effective in those who are physically active, suggesting an intricate, but currently undefined, relationship between iron status, exercise, and physical performance capacity. A combined analysis of iron status, exercise training, and physical performance in Chinese women could illuminate interactions between these factors and their role in diabetes and obesity reduction.

One common treatment for the symptoms of iron deficiency is the traditional Chinese herbal treatment, Ba-Zhen-Ke-Li (BZKL). While studies have shown that BZKL impacts expression of some iron-related proteins and increases endurance performance in rats, no studies have examined the efficacy of BZKL in improving iron markers or physical performance in humans. This study will compare the efficacy of BZKL in improving iron status and physical performance with that of ferrous sulfate supplementation.

Significance and Specific Aims:

The goal of the proposed research is to clarify the relationship between iron status, physical performance, and aerobic exercise training. By conducting an iron intervention study in combination with an exercise training program, the investigators can examine the modifying effect of iron status on the physical performance changes from aerobic exercise training as well as the modifying effect of participation in aerobic exercise in maintenance of iron status. To achieve this goal, a randomized double-blind, placebo controlled trial will be conducted with Chinese collegiate women.

The proposed work will be organized along three specific aims:

Aim I: To determine how changes in iron status, alone or in combination with exercise training, influence physical performance. Hypothesis: Subjects who both improve iron status and receive exercise training will show improvements in physical performance greater than the additive improvements resulting from either treatment alone. This result would suggest iron replete individuals benefit more from exercise training than those who are iron deficient.

Aim II: To determine how aerobic exercise training affects the maintenance of iron homeostasis. Hypothesis: Subjects participating in exercise training will show smaller improvements in iron status from iron supplementation than sedentary subjects who receive the same iron supplementation. This would suggest regular exercise training negatively impacts iron absorption, iron excretion and/or iron homeostasis.

Aim III: To determine whether BZKL can be used as an alternative to iron supplementation for improving iron status or physical performance of iron deficient, non-anemic women. Hypothesis: Those women who receive BZKL will improve in iron status and physical performance measures more than those who receive placebo.

The proposed research in Aims 1 and 2 is important because there is no known explanation for the observed relationships between iron, exercise training, and physical performance in IDNA. This research will allow clarification of the role that iron status plays in modifying the effects of exercise training on physical performance as well as whether participation in exercise impacts effectiveness of iron supplementation in improving iron status.

The long-term significance of this research is that establishing these relationships will further the current understanding of how iron status impacts and is impacted by aerobic exercise and physical performance. This knowledge could lead to improved physical activity interventions, which help reduce chronic diseases like obesity and diabetes in populations with high prevalence of ID, such as the U.S. and China. It will also help to inform iron interventions designed to alleviate ID in physically active populations, such as rural Chinese laborers and women in developed countries who participate in aerobic training to improve fitness.

Research Design and Methods:

Participants will be female subjects between the ages of 18-26 years with low body iron but normal hemoglobin (Hb) levels, (ferritin <20 μg/L and Hb > 120 g/L) who are otherwise healthy.

The study will be a randomized double-blind, placebo controlled trial with a 3x2 design. Power calculations were based on the pilot study performed by the investigators in Shanghai in 2013 and a study by Brownlie et al. Sample size was calculated to require 24 women per group, which was expanded to 29 subjects per group to allow for sample dropout. Subjects will be randomized to receive either 50mg of ferrous sulfate capsule twice a day (20mg elemental iron/day), 6 mg of BaZhen KeLi, or identical placebo capsules for 8 weeks. Half of each supplement group will also be randomly assigned to receive 8 weeks of aerobic exercise training (5 days/week, 25 minutes/day) or no training.

At weeks 0, 4, and 8 subjects will complete the following:

  1. Anthropometric measurements (height, weight, skinfold thickness)
  2. Physical activity and 4-day dietary intake questionnaires
  3. Resting venous blood draw for iron status assessment
  4. Exercise testing (VO2max test and energetic efficiency test)

To address Aims 1 and 2, the investigators will compare energetic efficiency, maximum ability to use oxygen, ventilatory threshold, and blood lactate concentrations at baseline, after supplementation (or placebo), and after exercise training (or no training). The 3x2 study design will allow for the determination of whether subjects receiving iron benefit more from exercise training. The investigators will also examine whether participating in exercise training affects iron homeostasis or lowers iron status.

Being tested
Iron trained, Iron Untrained, BZKL Trained, BZKL Untrained, Placebo Trained
Keywords
iron deficiency, anemia, exercise training, aerobic, performance, Chinese medicine, BaZhen KeLi
Medical subject headings
Iron Deficiencies, Anemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Iron trainedDietary supplement

    1. Ferrous sulfate: 100 mg/day of FeSO4 dosed in 2 capsules taken individually by mouth with breakfast and dinner. Capsules were made with FeSO4 and dextrose. Analysis has shown that each capsule contains 11mg of elemental iron, which is expected to be absorbed at roughly 33% bioavailability.
    2. Aerobic Training: 25 minutes/day, 5 days/week for 8 weeks working at an intensity between 75-85% of age-predicted maximum heart rate.
  • Iron UntrainedDietary supplement

    1. Ferrous sulfate: 100 mg/day of FeSO4 dosed in 2 capsules taken individually by mouth with breakfast and dinner. Capsules were made with FeSO4 and dextrose. Analysis has shown that each capsule contains 11mg of elemental iron, which is expected to be absorbed at roughly 33% bioavailability.
  • BZKL TrainedDietary supplement

    1. BaZhen KeLi capsules: Traditional Chinese herbal supplement composed of: Radix Paeoniae Alba (White peony root), Rhizoma Atractylodis (Atractylodes), Rhizoma Chuanxiong (Chuanxiong), Radix Angelicae Sinensis (Angelica), Radix Codonopsis Pilosula (Codonopsis), Poria cocos (Poria), licorice, and Rehmannia glutinosa Each pill contained 5g of licorice and 10g of all other ingredients. Dosed in 2 capsules taken individually by mouth with breakfast and dinner. Analysis has shown that each capsule contained 0.5mg of elemental iron.
    2. Aerobic Training: 25 minutes/day, 5 days/week for 8 weeks working at an intensity between 75-85% of age-predicted maximum heart rate.
  • BZKL UntrainedDietary supplement

    1. BaZhen KeLi capsules: Traditional Chinese herbal supplement composed of: Radix Paeoniae Alba (White peony root), Rhizoma Atractylodis (Atractylodes), Rhizoma Chuanxiong (Chuanxiong), Radix Angelicae Sinensis (Angelica), Radix Codonopsis Pilosula (Codonopsis), Poria cocos (Poria), licorice, and Rehmannia glutinosa Each pill contained 5g of licorice and 10g of all other ingredients. Dosed in 2 capsules taken individually by mouth with breakfast and dinner. Analysis has shown that each capsule contained 0.5mg of elemental iron.
  • Placebo TrainedDietary supplement

    1. Aerobic Training: 25 minutes/day, 5 days/week for 8 weeks working at an intensity between 75-85% of age-predicted maximum heart rate.
  • Placebo UntrainedDietary supplement

    No intervention

Study groups in NCT03002090
Study groupRoleWhat they receive
Iron trainedExperimentalNot described
Receives: Dietary Supplement: Iron trained
Iron UntrainedExperimentalNot described
Receives: Dietary Supplement: Iron Untrained
BZKL TrainedExperimentalNot described
Receives: Dietary Supplement: BZKL Trained
BZKL UntrainedExperimentalNot described
Receives: Dietary Supplement: BZKL Untrained
Placebo TrainedExperimentalNot described
Receives: Dietary Supplement: Placebo Trained
Placebo UntrainedPlacebo comparatorNot described
Receives: Dietary Supplement: Placebo Untrained

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Concentration of serum ferritin in µg/L

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.

  2. Concentration of soluble transferrin receptor in mg/L

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.

  3. Concentration of hemoglobin g/L

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.

  4. Concentration of alpha-1-acid glycoprotein in g/L

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.

  5. Concentration of C-reactive protein in mg/L

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.

Secondary outcomes (2)
  1. Human performance as assessed by maximal capacity for oxygen uptake (mL/min/kg body weight)

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change from weeks 0 to 8. Change from weeks 0 to 4.

  2. Human performance as assessed by energetic efficiency (in %)

    Changes from week 0 to weeks 4 and 8 measured both within and between groups.

    Measured: Change from weeks 0 to 8. Change from weeks 0 to 4.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2016 (estimated)
  2. Study startAug 2014
  3. Primary completionJun 2015
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
109 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03002090
Sponsor's protocol ID
IRB #: 1402004495
Status last verified
Dec 2016
First submitted
14 Dec 2016
Last updated
23 Dec 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Pompano LM, Haas JD. Increasing Iron Status through Dietary Supplementation in Iron-Depleted, Sedentary Women Increases Endurance Performance at Both Near-Maximal and Submaximal Exercise Intensities. J Nutr. 2019 Feb 1;149(2):231-239. doi: 10.1093/jn/nxy271.

    PubMed 30649365
  • Pompano LM, Haas JD. Efficacy of iron supplementation may be misinterpreted using conventional measures of iron status in iron-depleted, nonanemic women undergoing aerobic exercise training. Am J Clin Nutr. 2017 Dec;106(6):1529-1538. doi: 10.3945/ajcn.117.152777. Epub 2017 Nov 1.

    PubMed 29092885

Questions about this trial

What is this clinical trial studying?

A study testing Iron trained, Iron Untrained and BZKL Trained in people with Iron Deficiency Without Anemia, run by Cornell University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Concentration of serum ferritin in µg/L (time frame: Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03002090, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2016; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in